Skip to main content

Gates Foundation provides $20 million for OraQuick HIV Self-Test

The Bill & Melinda Gates Foundation will provide $20 million to offer 50 developing nations OraSure Technologies Inc.'s (Nasdaq: OSUR) OraQuick HIV Self-Test at an affordable price. The stock price climbed $1.58 to close at $17.30.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.